Vice Chairs Named for Neurology and Rehabilitation Medicine
Brett Kissela, MD, Albert Barnes Voorheis Professor and Chair of Neurology and Rehabilitation Medicine, has announced the following vice chair appointments:
- Rob Neel, MD: Vice chair of education.
- Kim Seroogy, PhD: Vice chair of basic research.
- Reena Shah, MD: Vice chair of clinical services.
- Daniel Woo, MD: Vice chair of clinical research.
Neel received his MD from the UC College of Medicine. He did his intern year at Christ Hospital, and his neurology residency and neuro-physiology fellowship at UC. He became the assistant residency program director in 2005, then the program director for the residency in 2010, revising the educational programming for the residency, including a specialty specific neurology didactic two year curriculum. Educationally, he has helped develop the Baseline Resident Assessment of Clinical Knowledge for all incoming residents across the institution and has served on the Graduate Medical Education Committee and Program Directors Committee since 2008. In the past two years, he became chair of the M3/4 Medical Student Education Committee and has taken on several key roles in the curriculum of the medical school.
Seroogy received his PhD in neurobiology from the University of California, Irvine. He performed postdoctoral research at the Karolinska Institute in Stockholm and at the University of North Carolina, Chapel Hill. After 12 years in the Department of Anatomy and Neurobiology at the University of Kentucky, he joined UC in 2003 as professor of neurology and director of the Selma Schottenstein Harris Laboratory for Research in Parkinsons. He currently serves as research director of the Gardner Family Center for Parkinsons Disease and Movement Disorders, and for eight years has served as the neurology and rehabilitation medicine departments vice chair of basic research. He has been a member of several NIH study sections and is past president of the Ohio Miami Valley Chapter of the Society for Neuroscience. He directs the UC Neuroscience Graduate Program and chairs the College of Medicine Committee on Graduate Education.
Shah graduated from Tufts School of Medicine and completed residency at the University of Maryland Medical Center where she served as chief resident. She worked as a neuro hospitalist in Lexington, Ky., prior to joining UC. There she helped establish the neuro-hospitalist service, provided NP training and provided tele-medicine consultative services to six other affiliated regional hospitals. Since arriving at UC, she has spent the majority of her time providing general neurology clinical services. She has served as division director for the General Neurology division, manages the inpatient Nurse Practitioner service and serves on the Clinical Operations Committee. She has pursued furthering her management and leadership skills in these roles and via a recent physician leadership program.
Woo received his MD from the UC College of Medicine. He completed his residency at the Cleveland Clinic and returned to UC as a stroke fellow. He began with multiple small pilot grants that led to a K-23 award during which he received a masters of science in molecular genetics. For his early research success, he received the Robert G. Siekert American Heart Association New Investigator in Stroke Award. Since then, he has obtained funding as principal investigator on two R-01s and is multiple PI on a third R-01. With these grants, he is currently ranked among the top 10 PIs in total funding from NINDS. He also served for many years as a member of the IRB and ultimately served for several years as vice chair of the IRB. He created the post-approval monitoring program which performed a random review of research protocols throughout UC which included an audit of all FDA IND programs for quality assurance and quality improvement. He is currently co-director of the Center for Environmental Genetics Career Development Core and will be taking over the UC Neurology lead role for the NeuroNEXT network.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.